113 related articles for article (PubMed ID: 19932195)
21. Galectin-9 administration ameliorates CVB3 induced myocarditis by promoting the proliferation of regulatory T cells and alternatively activated Th2 cells.
Lv K; Xu W; Wang C; Niki T; Hirashima M; Xiong S
Clin Immunol; 2011 Jul; 140(1):92-101. PubMed ID: 21507728
[TBL] [Abstract][Full Text] [Related]
22. Development of troponin autoantibodies in experimental coxsackievirus B3 myocarditis.
Latva-Hirvelä J; Kytö V; Saraste A; Eriksson S; Vuorinen T; Pettersson K; Saukko P
Eur J Clin Invest; 2009 Jun; 39(6):457-62. PubMed ID: 19397694
[TBL] [Abstract][Full Text] [Related]
23. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
24. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
[TBL] [Abstract][Full Text] [Related]
25. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
Huber SA
Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
[TBL] [Abstract][Full Text] [Related]
26. Role of MIP-2 in coxsackievirus B3 myocarditis.
Kishimoto C; Kawamata H; Sakai S; Shinohara H; Ochiai H
J Mol Cell Cardiol; 2000 Apr; 32(4):631-8. PubMed ID: 10756119
[TBL] [Abstract][Full Text] [Related]
27. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis.
Sonderegger I; Röhn TA; Kurrer MO; Iezzi G; Zou Y; Kastelein RA; Bachmann MF; Kopf M
Eur J Immunol; 2006 Nov; 36(11):2849-56. PubMed ID: 17039570
[TBL] [Abstract][Full Text] [Related]
28. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
Leipner C; Borchers M; Merkle I; Stelzner A
J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
[TBL] [Abstract][Full Text] [Related]
29. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
30. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF
Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238
[TBL] [Abstract][Full Text] [Related]
31. [Interleukin-17 contributes to the macrophage secretion of interleukin-27 in a murine model of viral myocarditis].
Kong Q; Gao M; Xue Y; Pan X; Lai W; Wu W
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 May; 42(5):428-32. PubMed ID: 25042924
[TBL] [Abstract][Full Text] [Related]
32. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3.
Seko Y; Takahashi N; Yagita H; Okumura K; Azuma M; Yazaki Y
J Pathol; 1999 May; 188(1):107-12. PubMed ID: 10398149
[TBL] [Abstract][Full Text] [Related]
33. Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis.
Li Z; Yue Y; Xiong S
Cardiovasc Pathol; 2013; 22(5):373-82. PubMed ID: 23523188
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of myocarditis and dilated cardiomyopathy.
Cihakova D; Rose NR
Adv Immunol; 2008; 99():95-114. PubMed ID: 19117533
[TBL] [Abstract][Full Text] [Related]
35. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus b3.
Seko Y; Takahashi N; Yagita H; Okumura K; Yazaki Y
J Pathol; 1997 Sep; 183(1):105-8. PubMed ID: 9370955
[TBL] [Abstract][Full Text] [Related]
36. [Alteration of interleukin-17/interferon-γ double positive cells in mice with Coxsackie virus induced myocarditis].
Yang F; Wu WF; Yan YL; Pang Y; Kong Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Dec; 39(12):1135-9. PubMed ID: 22336508
[TBL] [Abstract][Full Text] [Related]
37. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.
Lo CK; Lam QL; Sun L; Wang S; Ko KH; Xu H; Wu CY; Zheng BJ; Lu L
Arthritis Rheum; 2008 Sep; 58(9):2700-11. PubMed ID: 18759269
[TBL] [Abstract][Full Text] [Related]
38. Coxsackievirus B3 infection promotes generation of myeloid dendritic cells from bone marrow and accumulation in the myocardium.
Chen P; Chen R; Yang Y; Yu Y; Xie Y; Zou Y; Ge J; Chen H
Int Immunopharmacol; 2009 Oct; 9(11):1304-12. PubMed ID: 19664723
[TBL] [Abstract][Full Text] [Related]
39. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M
Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076
[TBL] [Abstract][Full Text] [Related]
40. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
